[1]
F. P. Wiharta, M. C. Saraswati, D. C. R. Abigail, and N. A. Chozie, “Emicizumab prophylaxis in severe hemophilia A with inhibitor: impact on quality of life and musculoskeletal outcomes”, Med J Indones, vol. 34, no. 3, pp. 214–8, Aug. 2025.